137 related articles for article (PubMed ID: 19219676)
1. Expression profile of human beta-defensin 3 in oral squamous cell carcinoma.
Kesting MR; Loeffelbein DJ; Hasler RJ; Wolff KD; Rittig A; Schulte M; Hirsch T; Wagenpfeil S; Jacobsen F; Steinstraesser L
Cancer Invest; 2009 Jun; 27(5):575-81. PubMed ID: 19219676
[TBL] [Abstract][Full Text] [Related]
2. Human beta-defensin-1, -2, and -3 exhibit opposite effects on oral squamous cell carcinoma cell proliferation.
Winter J; Pantelis A; Reich R; Martini M; Kraus D; Jepsen S; Allam JP; Novak N; Wenghoefer M
Cancer Invest; 2011 Mar; 29(3):196-201. PubMed ID: 21280982
[TBL] [Abstract][Full Text] [Related]
3. Loss of human beta-defensin 1, 2, and 3 expression in oral squamous cell carcinoma.
Joly S; Compton LM; Pujol C; Kurago ZB; Guthmiller JM
Oral Microbiol Immunol; 2009 Oct; 24(5):353-60. PubMed ID: 19702947
[TBL] [Abstract][Full Text] [Related]
4. Distinct signaling pathways leading to the induction of human β-defensin 2 by stimulating an electrolyticaly-generated acid functional water and double strand RNA in oral epithelial cells.
Gojoubori T; Nishio Y; Asano M; Nishida T; Komiyama K; Ito K
J Recept Signal Transduct Res; 2014 Apr; 34(2):97-103. PubMed ID: 24320144
[TBL] [Abstract][Full Text] [Related]
5. Surrounding cells affect the gene expression pattern of human beta-defensins in squamous cell carcinoma in vitro.
Kida-Takaoka S; Yamaai T; Mizukawa N; Murakami J; Iida S
Anticancer Res; 2014 Nov; 34(11):6443-9. PubMed ID: 25368244
[TBL] [Abstract][Full Text] [Related]
6. Pattern of expression of beta-defensins in oral squamous cell carcinoma.
Abiko Y; Mitamura J; Nishimura M; Muramatsu T; Inoue T; Shimono M; Kaku T
Cancer Lett; 1999 Aug; 143(1):37-43. PubMed ID: 10465335
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and therapeutic relevance of NY-ESO-1 expression in oral squamous cell carcinoma.
Ries J; Mollaoglu N; Vairaktaris E; Neukam FW; Nkenke E
Anticancer Res; 2009 Dec; 29(12):5125-30. PubMed ID: 20044626
[TBL] [Abstract][Full Text] [Related]
8. Clinico-pathological significance of MHC-I type chain-associated protein A expression in oral squamous cell carcinoma.
Wang J; Li C; Yang D; Jian XC; Jiang CH
Asian Pac J Cancer Prev; 2012; 13(2):715-8. PubMed ID: 22524849
[TBL] [Abstract][Full Text] [Related]
9. Human beta-defensin-1 suppresses tumor migration and invasion and is an independent predictor for survival of oral squamous cell carcinoma patients.
Han Q; Wang R; Sun C; Jin X; Liu D; Zhao X; Wang L; Ji N; Li J; Zhou Y; Ye L; Liang X; Jiang L; Liao G; Dan H; Zeng X; Chen Q
PLoS One; 2014; 9(3):e91867. PubMed ID: 24658581
[TBL] [Abstract][Full Text] [Related]
10. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
Chen YK; Hsue SS; Lin LM
Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
[TBL] [Abstract][Full Text] [Related]
11. [Expression of osteopontin mRNA in oral squamous cell carcinoma and normal oral mucosa].
Lu XZ; Yin XM; Feng YY; Duan LQ; Chen WT; Zhang CP
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1165-7. PubMed ID: 18676253
[TBL] [Abstract][Full Text] [Related]
12. PTEN expression and methylation status in oral squamous cell carcinoma.
Kurasawa Y; Shiiba M; Nakamura M; Fushimi K; Ishigami T; Bukawa H; Yokoe H; Uzawa K; Tanzawa H
Oncol Rep; 2008 Jun; 19(6):1429-34. PubMed ID: 18497947
[TBL] [Abstract][Full Text] [Related]
13. [Expression of MMP1 mRNA in oral squamous cell carcinoma and paired normal tissues].
Lü XZ; Zou YG; Yin XM; Chen WT; Zhang CP
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1362-4. PubMed ID: 18753061
[TBL] [Abstract][Full Text] [Related]
14. The retinoic acid receptor-beta (RAR-beta) mRNA expression in the oral squamous cell carcinoma associated with betel quid use.
Kao SY; Tu HF; Chang KW; Chang CS; Yang CC; Lin SC
J Oral Pathol Med; 2002 Apr; 31(4):220-6. PubMed ID: 12076325
[TBL] [Abstract][Full Text] [Related]
15. Different expression patterns of beta-defensins in human squamous cell carcinomas.
Yoshimoto T; Yamaai T; Mizukawa N; Sawaki K; Nakano M; Yamachika E; Sugahara T
Anticancer Res; 2003; 23(6C):4629-33. PubMed ID: 14981906
[TBL] [Abstract][Full Text] [Related]
16. Expression profiling of CYP1B1 in oral squamous cell carcinoma: counterintuitive downregulation in tumors.
Pradhan S; Nagashri MN; Gopinath KS; Kumar A
PLoS One; 2011; 6(11):e27914. PubMed ID: 22114726
[TBL] [Abstract][Full Text] [Related]
17. Decreased gene expression of human beta-defensin-1 in the development of squamous cell carcinoma of the oral cavity.
Wenghoefer M; Pantelis A; Dommisch H; Reich R; Martini M; Allam JP; Novak N; Bergé S; Jepsen S; Winter J
Int J Oral Maxillofac Surg; 2008 Jul; 37(7):660-3. PubMed ID: 18346877
[TBL] [Abstract][Full Text] [Related]
18. [Expression of large tumor suppressor homolog 2 gene and its promotor methylation in oral squamous cell carcinoma].
Yue ZW; Liu JZ
Zhonghua Kou Qiang Yi Xue Za Zhi; 2017 Sep; 52(9):569-573. PubMed ID: 29972924
[No Abstract] [Full Text] [Related]
19. Dual role of CCL3/CCR1 in oral squamous cell carcinoma: implications in tumor metastasis and local host defense.
Silva TA; Ribeiro FL; Oliveira-Neto HH; Watanabe S; Alencar Rde C; Fukada SY; Cunha FQ; Leles CR; Mendonça EF; Batista AC
Oncol Rep; 2007 Nov; 18(5):1107-13. PubMed ID: 17914560
[TBL] [Abstract][Full Text] [Related]
20. Pattern of mRNA expression of beta-defensins in basal cell carcinoma.
Gambichler T; Skrygan M; Huyn J; Bechara FG; Sand M; Altmeyer P; Kreuter A
BMC Cancer; 2006 Jun; 6():163. PubMed ID: 16796735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
